🎯 check Sorafenib (BAY 43-9006) product page
Sorafenib is an ATP-competitive multikinase inhibitor. It affects MAPK signaling by blocking ATP sites, inhibiting tumor growth.
Sorafenib (BAY 43-9006) Mechanism of Action: Raf Inhibition in Hepatocellular Carcinoma Cell Research
Sorafenib (BAY 43-9006) MOA：Targeting Raf/MAPK signaling pathway for Hepatocellular Carcinoma Drug Resistance